Astrana Health, Inc.
ASTH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $1 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $2 | $1 | $3 |
| Revenue | $2 | $1 | $1 | $1 |
| % Growth | 46.7% | 21.2% | 47.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 13.3% | 15.5% | 17.4% | 23% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 7% | 8.9% | 9.8% | 13% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 2.1% | 4.4% | 3.9% | 8.9% |
| EPS Diluted | 0.9 | 1.29 | 0.99 | 1.52 |
| % Growth | -30.2% | 30.3% | -34.9% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |